Grimes & Company’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-3,007
| Closed | -$225K | – | 301 |
|
|
2021
Q3 | $225K | Sell |
3,007
-473
| -14% | -$35.4K | 0.01% | 272 |
|
|
2021
Q2 | $322K | Buy |
3,480
+300
| +9% | +$27.8K | 0.01% | 235 |
|
|
2021
Q1 | $282K | Sell |
3,180
-233
| -7% | -$20.7K | 0.01% | 234 |
|
|
2020
Q4 | $318K | Buy |
3,413
+48
| +1% | +$4.47K | 0.02% | 213 |
|
|
2020
Q3 | $214K | Buy |
+3,365
| New | +$214K | 0.01% | 233 |
|